The cGMP Signaling Pathway as a Therapeutic Target in Heart Failure With Preserved Ejection Fraction
Open Access
- 18 November 2013
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of the American Heart Association
- Vol. 2 (6), e000536
- https://doi.org/10.1161/jaha.113.000536
Abstract
No abstract availableKeywords
This publication has 112 references indexed in Scilit:
- Abnormal haemodynamic response to exercise in heart failure with preserved ejection fractionEuropean Journal of Heart Failure, 2011
- sGCα1 mediates the negative inotropic effects of NO in cardiac myocytes independent of changes in calcium handlingAmerican Journal of Physiology-Heart and Circulatory Physiology, 2011
- Dietary nitrite and nitrate: a review of potential mechanisms of cardiovascular benefitsEuropean Journal of Nutrition, 2011
- Heart failure with preserved ejection fraction: pathophysiology, diagnosis, and treatmentEuropean Heart Journal, 2010
- Global Cardiovascular Reserve Dysfunction in Heart Failure With Preserved Ejection FractionJournal of the American College of Cardiology, 2010
- Contractility and Ventricular Systolic Stiffening in Hypertensive Heart Disease: Insights Into the Pathogenesis of Heart Failure With Preserved Ejection FractionJournal of the American College of Cardiology, 2009
- Pulmonary Hypertension in Heart Failure With Preserved Ejection Fraction: A Community-Based StudyJournal of the American College of Cardiology, 2009
- Ventricular–Vascular Interaction in Heart FailureHeart Failure Clinics, 2008
- NO-independent stimulators and activators of soluble guanylate cyclase: discovery and therapeutic potentialNature Reviews Drug Discovery, 2006
- NO‐independent activation of soluble guanylate cyclase prevents disease progression in rats with 5/6 nephrectomyBritish Journal of Pharmacology, 2006